HEALTH RELATED QUALITY OF LIFE IN BREAST CANCER PATIENTS UNDERGOING CURRENT CHEMOTHERAPY PROTOCOLS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

HATAM N.; BASTANI P.; AHMADLOO N.; KIADALIRI A.A.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Journal of Kerman University of Medical Sciences Year:2012 | Volume:19 | Issue:1 Page(s): 49-58

Download Full-Text

Persian Verion

View:

1,206

Download:

Cites:

Information Journal Paper

Title

HEALTH RELATED QUALITY OF LIFE IN BREAST CANCER PATIENTS UNDERGOING CURRENT CHEMOTHERAPY PROTOCOLS

Author(s)

HATAM N. | BASTANI P. | AHMADLOO N. | KIADALIRI A.A. | Issue Writer Certificate

Keywords

QUALITY OF LIFEQ2

ADJUVANT CHEMOTHERAPYQ2

BREAST NEOPLASMSQ2

NODE POSITIVEQ2

Abstract

Background & Aims: Health related QUALITY OF LIFE is one of the important concepts that nowadays is considered along with other quantitative criteria like life expectancy and survival in health service systems, but its significance is more obvious in degenerative diseases and long term treatments such as cancers. In this study we compared health related QUALITY OF LIFE in breast cancer patients undergoing either Docetaxel –Adriamicine - Cyclophosphamide (TAC) or 5-FU- Adriamicine– Cyclophosphamide (FAC) regimens.Method: This study was conducted in a double blind cohort design on 100 patients with positive - node breast cancer treated by TAC or FAC regimens. The international standard questionnaire (EORTC QLQC30) was used to evaluate health related QUALITY OF LIFE at the start and end points of chemotherapy period. Data were analyzed by independent t-test at the significant level of 0.05.Results: Results showed the same scores of QUALITY OF LIFE at the first session of chemotherapy in both groups and in 4- month follow up, at the end of chemotherapy, mean score of QUALITY OF LIFE in both groups decreased but it reduced more in TAC group.Conclusion: Chemotherapy regimens can decrease patients’ QUALITY OF LIFE greatly. So reinforcing the relationship between patients and their families, society and treatment team in addition with using supportive methods and counseling groups can maintain the level of patients’ QUALITY OF LIFE greatly.

Cites

References

No record.

Cite

APA: Copy

HATAM, N., BASTANI, P., AHMADLOO, N., & KIADALIRI, A.A.. (2012). HEALTH RELATED QUALITY OF LIFE IN BREAST CANCER PATIENTS UNDERGOING CURRENT CHEMOTHERAPY PROTOCOLS. JOURNAL OF KERMAN UNIVERSITY OF MEDICAL SCIENCES, 19(1), 49-58. SID. https://sid.ir/paper/430/en

Vancouver: Copy

HATAM N., BASTANI P., AHMADLOO N., KIADALIRI A.A.. HEALTH RELATED QUALITY OF LIFE IN BREAST CANCER PATIENTS UNDERGOING CURRENT CHEMOTHERAPY PROTOCOLS. JOURNAL OF KERMAN UNIVERSITY OF MEDICAL SCIENCES[Internet]. 2012;19(1):49-58. Available from: https://sid.ir/paper/430/en

IEEE: Copy

N. HATAM, P. BASTANI, N. AHMADLOO, and A.A. KIADALIRI, “HEALTH RELATED QUALITY OF LIFE IN BREAST CANCER PATIENTS UNDERGOING CURRENT CHEMOTHERAPY PROTOCOLS,” JOURNAL OF KERMAN UNIVERSITY OF MEDICAL SCIENCES, vol. 19, no. 1, pp. 49–58, 2012, [Online]. Available: https://sid.ir/paper/430/en

Related Journal Papers